⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Lost Money on Alvotech (ALVO)? Contact Levi & Korsinsky to Protect Your Rights
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
globenewswire.com
ALVO
Ongoing Securities Investigation into Alvotech (ALVO) - Contact Levi & Korsinsky
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Investigation Underway: Alvotech (ALVO) - Contact Levi & Korsinsky Over Securities Law Violations
accessnewswire.com
ALVO
Lost Money on Alvotech (ALVO)? Contact Levi & Korsinsky to Protect Your Rights
accessnewswire.com
ALVO
Investigation Opened on Behalf of Alvotech (ALVO) Shareholders - Contact Levi & Korsinsky
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
globenewswire.com
ALVO